These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7585149)
1. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Maciejewski JP; Weichold FF; Young NS; Cara A; Zella D; Reitz MS; Gallo RC Nat Med; 1995 Jul; 1(7):667-73. PubMed ID: 7585149 [TBL] [Abstract][Full Text] [Related]
2. Targeting HIV reverse transcriptase in novel ways. Wainberg MA; Gu Z Nat Med; 1995 Jul; 1(7):628-9. PubMed ID: 7585138 [No Abstract] [Full Text] [Related]
3. Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1. Snowden W; Coughlan N; Tisdale M; Stammers DK J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1187-93. PubMed ID: 7693912 [TBL] [Abstract][Full Text] [Related]
4. Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family. Gargano N; Biocca S; Bradbury A; Cattaneo A J Virol; 1996 Nov; 70(11):7706-12. PubMed ID: 8892891 [TBL] [Abstract][Full Text] [Related]
5. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120. Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072 [TBL] [Abstract][Full Text] [Related]
6. Serum capacity to inhibit reverse transcriptase in vitro distinguishes HIV-1 infection from HIV-2 or SIV infection. Wolfs TF; Geelen JL; Schellekens H; Barin F; Dekker JT; Goudsmit J AIDS Res Hum Retroviruses; 1989 Oct; 5(5):535-40. PubMed ID: 2480153 [TBL] [Abstract][Full Text] [Related]
7. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains. Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment. Gargano N; Cattaneo A J Gen Virol; 1997 Oct; 78 ( Pt 10)():2591-9. PubMed ID: 9349480 [TBL] [Abstract][Full Text] [Related]
9. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus. Ichimura H; Levy JA Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050 [TBL] [Abstract][Full Text] [Related]
10. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. Levy-Mintz P; Duan L; Zhang H; Hu B; Dornadula G; Zhu M; Kulkosky J; Bizub-Bender D; Skalka AM; Pomerantz RJ J Virol; 1996 Dec; 70(12):8821-32. PubMed ID: 8971011 [TBL] [Abstract][Full Text] [Related]
11. Differentiation between human immunodeficiency virus type 1 (HIV-1) and HIV-2 isolates by nonradioisotopic reverse transcriptase-typing assay. Urabe T; Sano K; Nakano T; Odawara F; Lee MH; Otake T; Okubo S; Hayami M; Misaki H; Baba M J Clin Microbiol; 1994 Aug; 32(8):1870-5. PubMed ID: 7527425 [TBL] [Abstract][Full Text] [Related]
13. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments. Duan L; Zhu M; Bagasra O; Pomerantz RJ Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies. Mhashilkar AM; LaVecchio J; Eberhardt B; Porter-Brooks J; Boisot S; Dove JH; Pumphrey C; Li X; Weissmahr RN; Ring DB; Ramstedt U; Marasco WA Hum Gene Ther; 1999 Jun; 10(9):1453-67. PubMed ID: 10395371 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Levin R; Mhashilkar AM; Dorfman T; Bukovsky A; Zani C; Bagley J; Hinkula J; Niedrig M; Albert J; Wahren B; Göttlinger HG; Marasco WA Mol Med; 1997 Feb; 3(2):96-110. PubMed ID: 9085253 [TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of murine monoclonal antibodies reactive against N-terminal and other regions of HIV-1 reverse transcriptase. Li X; Amandoron E; Wainberg MA; Parniak MA J Med Virol; 1993 Mar; 39(3):251-9. PubMed ID: 7682257 [TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-mediated expression in primary human T cells of an endoplasmic reticulum-retained CD4 chimera inhibits human immunodeficiency virus type-1 replication. San José E; Muñoz-Fernández MA; Alarcón B Hum Gene Ther; 1998 Jun; 9(9):1345-57. PubMed ID: 9650619 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to reverse transcriptase in HIV infection and progression to AIDS. Schattner A; Milchan R; Kaminchik J; Yavin Z; Bentwich Z Immunol Lett; 1992 Jul; 33(2):207-10. PubMed ID: 1280249 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of heat inactivation of reverse transcriptase of human immunodeficiency virus type 1 by seropositive sera. Nagumo T; Takeuchi Y; Hoshino H Jpn J Cancer Res; 1992 Jun; 83(6):594-600. PubMed ID: 1379577 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of enzyme inhibition mediated by anti-reverse transcriptase antibodies from HIV type 1-infected individuals. Devico AL; Rahman R; Sarngadharan MG; Veronese FD AIDS Res Hum Retroviruses; 1994 Aug; 10(8):953-60. PubMed ID: 7529034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]